A WSJ article about this drug is in the cholesterol forum, focused on the FDA review process. Two drugs paid to jump the queue in the review process...maybe end July?

http://forum.lowcarber.org/showthread.php?t=468095

Dr Kendrick has written about these drugs before, though it might have been part of other articles on cholesterol lowering medications. The cost will be a big factor in their success, there have been other articles about push-back from the likes of CVS, but the studies on whether or not reducing LDL actually reduces CVD aren't due until end of 2018!